ltd. india largest drug manufacturer largest u.s. suppliers month fda banned ranbaxy plant producing distributing drug ingredients u.s. market firm caught retesting materials produce acceptable findings failed time company investigated reported products failed initially fda says 2008 fda issued bans ranbaxy plants present ranbaxy human drug products imported u.s. company pleaded guilty federal drug safety violations $ 500 million settlement fda whistleblower inside ranbaxy came forward separately ranbaxy experienced quality control lapses allowed pieces glass generic lipitor tablets 2012 ranbaxy not indian company cited sending flawed products u.s. received fda admonishments critics blamed lackluster fda inspection practices mishaps noting fda